Gabi Vohwinkel

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann et al. · Oncogene · 2018 · 107 citations · Full text

Medicine, Immunology, Oncology +17

Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects

Jasmin Wellbrock, Emily Latuske, Julian Köhler et al. · Clinical Cancer Research · 2015 · 103 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer

Eckart Laack, Annika Köhler, C. Kugler et al. · Annals of Oncology · 2002 · 95 citations · Full text

Medicine, Oncology, Pathology +10

Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome

Walter Fiedler, R.-P. Henke, S�leyman Erg�n et al. · Cancer · 2000 · 39 citations

Medicine, Hematology, Pathology +17

Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma

Franziska Brauneck, Pauline Weimer, Julian Schulze zur Wiesch et al. · Frontiers in Medicine · 2021 · 39 citations · Full text

Life Sciences, Hematology, Immunology +17